Letters

Malaria prophylaxis

BMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.6998.190b (Published 15 July 1995) Cite this as: BMJ 1995;311:190
  1. G C Cook
  1. Consultant physician Hospital for Tropical Diseases, London NW1 0PE

    Mefloquine toxicity should limit its use to treatment alone

    EDITOR,--Reviews of chemoprophylaxis against malaria for travellers are welcome; numerous problems surround the advisability of current regimens.1 Two recently published studies have supported the advisability of using mefloquine for short term chemoprophylaxis in sub-Saharan Africa.2 3 As a result, the authors of the recent update advocate use of mefloquine for most parts of this continent even though the combination of chloroquine plus proguanil remains moderately effective in most countries under …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe